YelenaZGinzburgMD

Hematology • New York, NY

Assistant Clinical Professor, Medicine, Hematology, Albert Einstein College of Medicine

Join to view full profile

Dr. Ginzburg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ginzburg's full profile

Already have an account?

Office
10 E 102nd St
New York, NY 10029
Phone+1 212-241-6756

Fax+1 212-423-0522

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2002 - 2005
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1999 - 2002
Tel Aviv University SacklerClass of 1999

Certifications & Licensure

NY State Medical License 2005 - 2026
CT State Medical License 2014 - 2015
NJ State Medical License 2011 - 2015
PA State Medical License 2014 - 2014
American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy.
Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, Amylou Dueck, Douglas Tremblay
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-01
Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model.
Haihang Zhang, Rui Liu, Zheng Fang, Ling Nie, Yanlin Ma
Blood Advances. 2024-08-13
3 citations
The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling.
Ugo Sardo, Prunelle Perrier, Kevin Cormier, Manon Sotin, Jean Personnaz
Blood. 2024-03-28

Abstracts/Posters

Aberrant Responsiveness of Erythropoiesis to Iron Deficiency in Polycythemia Vera
Yelena Ginzburg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

IRON: How to Manage When There is Too Much or Too Little of It
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Protagonist Therapeutics: More Good News Likely to ComeMarch 9th, 2023
Rusfertide Reduces Hematocrit Without Phlebotomy in Polycythemia VeraDecember 13th, 2021
Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology (ASH) 2020 Annual MeetingNovember 4th, 2020
Join now to see all

Grant Support

Understanding And Improving Iron Distribution And Erythropoiesis In Beta-ThalasseNational Heart, Lung, And Blood Institute2011–2012